These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 9280714

  • 1. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM, Berger ED, Heyne N, Klass M, Krämer D, Braun N, Wolf S, Risler T.
    Dtsch Med Wochenschr; 1997 Aug 01; 122(31-32):953-8. PubMed ID: 9280714
    [Abstract] [Full Text] [Related]

  • 2. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM, Klass M, Krämer D, Berger E, Heyne N, Braun N, Wolf S, Risler T.
    Int J Clin Pharmacol Ther; 1996 Nov 01; 34(11):504-9. PubMed ID: 8937934
    [Abstract] [Full Text] [Related]

  • 3. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar 01; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 4. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

  • 5. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG, Apperloo AJ, Rensma PL, Stegeman CA, Sluiter WJ, de Zeeuw D, de Jong PE.
    Kidney Int Suppl; 1997 Dec 28; 63():S58-62. PubMed ID: 9407423
    [Abstract] [Full Text] [Related]

  • 6. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 28; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 7. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
    Guidi E, Minetti EE, Cozzi MG.
    J Renin Angiotensin Aldosterone Syst; 2002 Mar 28; 3(1):40-5. PubMed ID: 11984747
    [Abstract] [Full Text] [Related]

  • 8. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
    Nephrol Dial Transplant; 2010 Jul 28; 25(7):2218-24. PubMed ID: 20106824
    [Abstract] [Full Text] [Related]

  • 9. Does L-arginine alter proteinuria and renal hemodynamics in patients with chronic glomerulonephritis and hypertension?
    Wolf SC, Erley CM, Kenner S, Berger ED, Risler T.
    Clin Nephrol; 1995 Jan 28; 43 Suppl 1():S42-6. PubMed ID: 7781205
    [Abstract] [Full Text] [Related]

  • 10. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May 28; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 11. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
    Erley CM, Komini E, Nicaeus T, Braun N, Wolf S, Risler T.
    Dtsch Med Wochenschr; 1994 Jan 28; 119(4):89-95. PubMed ID: 8299527
    [Abstract] [Full Text] [Related]

  • 12. Nephroprotection by antihypertensive agents.
    Schmieder RE.
    J Cardiovasc Pharmacol; 1994 Jan 28; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [Abstract] [Full Text] [Related]

  • 13. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
    Am J Kidney Dis; 2009 Apr 28; 53(4):606-16. PubMed ID: 19216016
    [Abstract] [Full Text] [Related]

  • 14. Renal hemodynamics in essential hypertensives treated with losartan.
    Erley CM, Bader B, Scheu M, Wolf S, Braun N, Risler T.
    Clin Nephrol; 1995 Jan 28; 43 Suppl 1():S8-11. PubMed ID: 7781206
    [Abstract] [Full Text] [Related]

  • 15. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients.
    Armentano RL, Graf S, Ramírez AJ, Espinosa JD, Brandani L, Baglivo H, Sánchez R.
    Medicina (B Aires); 2001 Jan 28; 61(5 Pt 1):535-40. PubMed ID: 11721319
    [Abstract] [Full Text] [Related]

  • 16. Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition.
    Berger ED, Bader BD, Ebert C, Risler T, Erley CM.
    J Hypertens; 2002 Apr 28; 20(4):739-43. PubMed ID: 11910311
    [Abstract] [Full Text] [Related]

  • 17. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 28; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 18. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM, Tareeva IE, Nosikov VV, Kamyshova ES, Gorashko NM, Chistiakov DA, Okonova EB, Troepol'skaia OV.
    Ter Arkh; 1999 Nov 28; 71(6):30-4. PubMed ID: 10420452
    [Abstract] [Full Text] [Related]

  • 19. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 28; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 20. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
    Am J Kidney Dis; 2006 May 28; 47(5):751-60. PubMed ID: 16632013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.